| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 200 | 96 | 9 | 8 | 4 | 4 | 9 | 12 | 4 | 11 | 3 | 3 | 7 | 2 | 5 | 4 | 10 | 5 | 5 | 8 | 9 | 16 | 9 | 7 | 5 | 7 | 3 |
| Expenses | 146 | 79 | 22 | 51 | 44 | 23 | 30 | 34 | 16 | 27 | 28 | 23 | 45 | 29 | 37 | 24 | 25 | 26 | 55 | 34 | 32 | 27 | 49 | 33 | 32 | 55 | 41 |
| EBITDA | 54 | 17 | -13 | -42 | -39 | -19 | -22 | -22 | -12 | -15 | -25 | -20 | -38 | -27 | -32 | -20 | -15 | -22 | -49 | -26 | -22 | -11 | -40 | -26 | -27 | -48 | -38 |
| Operating Profit % | 24 % | 11 % | -936 % | -2,025 % | -2,635 % | -1,517 % | -999 % | -290 % | -994 % | -196 % | -1,764 % | -1,383 % | -2,118 % | -2,341 % | -733 % | -467 % | -595 % | -494 % | -1,720 % | -1,208 % | -737 % | -768 % | -1,885 % | -1,267 % | -3,023 % | -2,032 % | -2,435 % |
| Depreciation | 6 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 47 | 11 | -14 | -44 | -40 | -20 | -23 | -23 | -13 | -17 | -26 | -22 | -39 | -28 | -34 | -21 | -16 | -23 | -51 | -28 | -24 | -13 | -42 | -28 | -28 | -50 | -39 |
| Tax | 21 | 7 | 0 | -4 | -14 | -0 | 0 | 2 | -3 | -1 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| Net Profit | 26 | 4 | -14 | -39 | -26 | -20 | -23 | -26 | -11 | -16 | -24 | -22 | -39 | -28 | -34 | -21 | -16 | -23 | -51 | -28 | -24 | -13 | -42 | -27 | -28 | -50 | -39 |
| EPS in ₹ | 2.04 | 0.30 | -1.13 | -3.10 | -2.05 | -1.56 | -1.79 | -2.01 | -0.82 | -1.23 | -1.92 | -1.70 | -3.08 | -2.22 | -2.50 | -1.63 | -1.12 | -1.51 | -2.90 | -1.17 | -1.10 | -0.58 | -1.92 | -1.22 | -1.29 | -2.27 | -1.79 |
Suven Life Sciences
122.30
+2.97
(2.49%)
Market Cap
2,667.04 Cr
EPS
-4.82
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
169.30
52 Week Low
82.95
PB Ratio
13.53
Debt to Equity
0.00
Sector
Healthcare Technology
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
701.80 | #1 28,250.05 | 58.30 | #1 3,579.20 | 9.66 | #1 510 | 17.58 | 47.25 | |
571.30 | 13,708.60 | 34.72 | 2,665.90 | 12.77 | 337 | 11.03 | 54.37 | |
122.30 | #3 2,667.04 | - | #8 32.80 | #1 49.09 | #8 -105 | #7 6.46 | 51.05 | |
917.35 | 2,038.61 | #1 31.16 | 322.30 | 0.22 | 41 | 112.87 | 45.21 | |
90.78 | 213.77 | - | 769.70 | -22.39 | -59 | 17.26 | 64.83 | |
8.26 | 122.19 | - | 67.20 | -65.97 | -120 | #1 2,371.43 | 46.60 | |
41.35 | 65.50 | 92.68 | 40.30 | 8.04 | -1 | 120.00 | 46.15 | |
16.00 | 26.30 | 33.09 | 80.00 | -3.26 | 2 | -80.00 | 37.86 | |
21.96 | 13.86 | - | 9.80 | 40.00 | -9 | -380.00 | 32.68 |
Growth Rate
Revenue Growth
49.09 %
Net Income Growth
-11.16 %
Cash Flow Change
0.44 %
ROE
23.48 %
ROCE
24.98 %
EBITDA Margin (Avg.)
-39.03 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 773 | 752 | 816 | 919 | 303 | 182 | 128 | 108 | 389 | 285 |
| Fixed Assets | 172 | 305 | 306 | 308 | 22 | 25 | 21 | 38 | 37 | 28 |
| Current Assets | 477 | 428 | 492 | 570 | 281 | 66 | 103 | 67 | 252 | 257 |
| Capital Work in Progress | 107 | 7 | 10 | 25 | 0 | 0 | 5 | 4 | 0 | 0 |
| Investments | 0 | 0 | 301 | 279 | 223 | 0 | 0 | 45 | 46 | 76 |
| Other Assets | 494 | 439 | 199 | 308 | 58 | 157 | 103 | 22 | 305 | 181 |
| Total Liabilities | 773 | 752 | 816 | 919 | 303 | 182 | 128 | 108 | 389 | 285 |
| Current Liabilities | 127 | 111 | 119 | 122 | 40 | 27 | 16 | 8 | 11 | 14 |
| Non Current Liabilities | 86 | 46 | 30 | 30 | 25 | 12 | 5 | 4 | 3 | 1 |
| Total Equity | 559 | 595 | 667 | 767 | 239 | 143 | 108 | 96 | 375 | 270 |
| Reserve & Surplus | 547 | 583 | 654 | 755 | 226 | 131 | 58 | 82 | 354 | 248 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 15 | 22 | 22 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 212 | -39 | -232 | 17 | -18 | 14 | -5 | -4 | 32 | -22 |
| Investing Activities | -110 | -39 | -311 | -1 | 30 | 146 | 56 | -22 | -248 | 94 |
| Operating Activities | 143 | 68 | 109 | 70 | -53 | -135 | -96 | -128 | -116 | -116 |
| Financing Activities | 179 | -68 | -30 | -52 | 5 | 3 | 35 | 146 | 396 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Nov 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 60.00 % | 60.00 % | 60.00 % | 60.00 % | 64.98 % | 64.98 % | 64.98 % | 64.98 % | 69.57 % | 69.57 % | 69.57 % | 69.57 % | 69.57 % | 69.57 % | 70.27 % | 70.27 % | 70.27 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.50 % | 0.54 % | 0.46 % | 0.45 % | 0.34 % | 0.34 % |
| DIIs | 0.21 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.13 % | 0.12 % | 0.11 % | 0.11 % | 0.08 % | 0.01 % | 0.12 % | 1.17 % | 1.17 % | 1.05 % | 1.06 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 33.92 % | 34.22 % | 33.19 % | 33.24 % | 28.69 % | 29.02 % | 27.37 % | 27.43 % | 22.98 % | 23.00 % | 23.29 % | 24.38 % | 24.05 % | 22.29 % | 22.66 % | 22.15 % | 22.31 % |
| Others | 5.87 % | 5.76 % | 6.79 % | 6.74 % | 6.31 % | 5.98 % | 7.52 % | 7.48 % | 7.34 % | 7.32 % | 7.06 % | 5.54 % | 5.72 % | 6.51 % | 5.46 % | 6.19 % | 6.04 % |
| No of Share Holders | 77,650 | 86,008 | 81,475 | 80,195 | 81,062 | 81,038 | 80,116 | 80,536 | 80,838 | 78,634 | 76,291 | 80,953 | 74,003 | 68,959 | 66,116 | 63,975 | 63,537 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1 | 1.5 | 1.5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 12.85 | 0.57 | 7.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
9 days ago
9 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20189 days ago
9 days agoDisclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 26, 2025
Mar 26, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015Mar 21, 2025
Mar 21, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 26, 2025
Feb 26, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 26, 2025
Feb 26, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 03, 2025
Feb 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 25, 2025
Jan 25, 2025Integrated Filing (Financial)Jan 24, 2025
Jan 24, 2025No Deviation(S) Or Variation(S) In The Use Of ProceedsJan 24, 2025
Jan 24, 2025Outcome Of The Board MeetingJan 24, 2025
Jan 24, 2025Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended December 31 2024 And Related MattersJan 16, 2025
Jan 16, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 08, 2025
Jan 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Jan 08, 2025Closure of Trading WindowDec 27, 2024
Dec 27, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 03, 2024
Dec 03, 2024Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 08, 2024
Nov 08, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 30, 2024
Oct 30, 2024Statement Of Deviation(S) Or Variation(S) For Quarter Ended 30Th September, 2024 Under Regulation 32 Of SEBI (LODR) Regulations, 2015Oct 29, 2024
Oct 29, 2024Outcome Of The Board Meeting - Financial Results For Quarter & Half-Year Ended 30/09/2024Oct 29, 2024
Oct 29, 2024Board Meeting Intimation for Consider And Approve Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30, 2024Oct 21, 2024
Oct 21, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 07, 2024
Oct 07, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 03, 2024
Oct 03, 2024Closure of Trading WindowSep 26, 2024
Sep 26, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 18, 2024
Sep 18, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 27, 2024
Aug 27, 2024Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 09, 2024
Aug 09, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2024
Aug 06, 2024Statement Confirming That There Were No Deviation(S) Or Variation(S) In The Use Of ProceedsAug 05, 2024
Aug 05, 2024Outcome Of The Board MeetingAug 05, 2024
Aug 05, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 02, 2024
Aug 02, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMAug 02, 2024
Aug 02, 2024Board Meeting Intimation for Board Meeting Of The Company To Be Held On Monday, August 05, 2024Jul 29, 2024
Jul 29, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 09, 2024
Jul 09, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 05, 2024
Jul 05, 2024Business Responsibility and Sustainability Reporting (BRSR)Jul 04, 2024
Jul 04, 2024Notice Of 35Th Annual General Meeting (AGM) Of The Company.Jul 04, 2024
Jul 04, 2024Reg. 34 (1) Annual Report.Jul 04, 2024
Jul 04, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 29, 2024
Jun 29, 2024Closure of Trading WindowJun 28, 2024
Jun 28, 2024Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011May 28, 2024
May 28, 2024Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 24, 2024
May 24, 2024Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 10, 2024
May 10, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2024
May 08, 2024Statement Of Deviation(S) Or Variation(S) For Quarter Ended 31St March, 2024May 06, 2024
May 06, 2024E-Annual General Meeting (AGM)May 06, 2024
May 06, 2024Re-Appointment Of Managing DirectorMay 06, 2024
May 06, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 06, 2024
May 06, 2024Grant Of Stock Options By The Nomination & Remuneration Committee Of The CompanyMay 06, 2024
May 06, 2024Technical Indicators
RSI(14)
Neutral 51.05
ATR(14)
Less Volatile 7.48
STOCH(9,6)
Neutral 39.86
STOCH RSI(14)
Neutral 38.01
MACD(12,26)
Bullish 0.08
ADX(14)
Weak Trend 14.58
UO(9)
Bearish 36.98
ROC(12)
Downtrend But Slowing Down -2.28
WillR(14)
Neutral -65.43
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
